Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
Marina T. Broz, Emily Y. Ko, Kristin Ishaya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors
Yuxuan Wang, Zhiqiang Sun, Zean Zhao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
The Cytotoxic Effect of Crocin and Chrysin on the AsPC-1 Pancreatic Cancer Cell Line is Related to Inhibition of Nutrient Uptake
Sara Pinto, Nelson Andrade, Francisca Carmo, et al.
PharmaNutrition (2025) Vol. 31, pp. 100432-100432
Open Access | Times Cited: 1
Glycolysis: A fork in the path of normal and pathological pregnancy
Rui Gou, Xiaohong Zhang
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 16
Autophagy and Female Fertility: Mechanisms, Clinical Implications, and Emerging Therapies
Abdel Halim Harrath, Md. Ataur Rahman, Sujay Kumar Bhajan, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1354-1354
Open Access | Times Cited: 5
The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications
Jiangxia Du, Minhui Shen, Jiajia Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Progression of bone-metastatic prostate cancer in a mouse model treated with a novel pan-class I GLUT inhibitor (DRB18)
Nathan K. Hoggard, Shiyu Yuan, M. Szczepaniak, et al.
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance
Anjali Kumari, Arpita Jha, Anju Tiwari, et al.
Archives of Oral Biology (2023) Vol. 150, pp. 105688-105688
Closed Access | Times Cited: 9
The Involvement of Glucose and Lipid Metabolism Alteration in Rheumatoid Arthritis and Its Clinical Implication
Tingting Luo, Yijin Wu, Qin Yin, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1837-1852
Open Access | Times Cited: 9
Correlations between class I glucose transporter expression patterns and clinical outcomes in non‐small cell lung cancer
Yoko Nakanishi, Momoko Iwai, Yukari Hirotani, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 27, pp. 2761-2769
Open Access | Times Cited: 7
The combined treatment with ketogenic diet and metformin slows tumor growth in two mouse models of triple negative breast cancer
Karen Schmidt, Amber Thatcher, Albert Grobe, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to Arsenite
Reem Ali, Abdallah Alhaj Sulaiman, Bushra Memon, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2682-2682
Open Access | Times Cited: 6
Systemic Reduction of Glut1 Normalizes Retinal Dysfunction, Inflammation, and Oxidative Stress in the Retina of Spontaneous Type 2 Diabetic Mice
Jacob J. Aiello, Maislin C. Bogart, Wai-Ting Chan, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 7, pp. 927-938
Open Access | Times Cited: 5
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer
Eduardo Ferreira, Dylan Ferreira, Marta Relvas‐Santos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3462-3462
Open Access | Times Cited: 1
Dual inhibitory potential of ganoderic acid A on GLUT1/3: computational and in vitro insights into targeting glucose metabolism in human lung cancer
Mona Alrasheed Bashir, Mohnad Abdalla, Changsheng Shao, et al.
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28569-28584
Open Access | Times Cited: 1
The Combined Treatment with Ketogenic Diet and Metformin Slows Tumor Growth in Two Mouse Models of Triple Negative Breast Cancer
Karen Schmidt, Amber Thatcher, Albert Grobe, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
SUV max as Predictor of Metastatic Disease on 18 F-FDG PET-CT in Hepatocellular Carcinoma
Wardah Ashfaq, Khurram Rehman, Abubaker Shahid, et al.
Journal of College of Physicians And Surgeons Pakistan (2024) Vol. 34, Iss. 04, pp. 394-399
Open Access
Recent progress in the development of therapies targeting molecular factors in breast cancer
Dominika Kunachowicz, Monika Birska, Karolina Kłosowska, et al.
Farmacja Polska (2024) Vol. 80, Iss. 3, pp. 189-204
Open Access
An alternative way to break the matrix barrier: an experimental study of a LIFU-mediated, visualizable targeted nanoparticle synergistic amplification for the treatment of malignant fibroblasts
Xing‐Zhong Zhao, Zhengchao Fan, Jianxin Zhou, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
In-silico identification and validation of Silibinin as a dual inhibitor for ENO1 and GLUT4 to curtail EMT signaling and TNBC progression
Dheepika Venkatesh, Shilpi Sarkar, Thirukumaran Kandasamy, et al.
Computational Biology and Chemistry (2024) Vol. 115, pp. 108312-108312
Closed Access
A novel pan class-I glucose transporter inhibitor DRB18 exhibits synergistic effects in vitro and in vivo with paclitaxel against human non-small cell lung cancer
Pratik Shriwas, Lindsey Bachmann, Ryan Ward, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of starvation-mimetic bioactive phytocomponent from Withania somnifera using in-silico molecular modelling and flow cytometry-based analysis for the management of malaria
Deepak Pradhan, Prativa Biswasroy, Sharvari Kulkarni, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 528-549
Closed Access
Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes
Elena de la Torre-Rubio, Laura Muñoz‐Moreno, Ana M. Bajo, et al.
Journal of Inorganic Biochemistry (2023) Vol. 247, pp. 112326-112326
Open Access
Page 1

Scroll to top